Synbio Tech Profit Margin

Synbio Tech (1295.TWO) currently reports a profit margin of 14.11% as of June 2026. That compares with 16.98% in the prior-year period — down 16.9% year over year. That is above the Healthcare sector average of 10.58%. Use the charts on this page to explore Synbio Tech's profit margin history and peer comparisons.

Synbio Tech's profit margin decreased from 16.98% to 14.11% — a 16.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Synbio Tech's profit margin of 14.11% is higher than the Healthcare sector average of 10.58%. That is roughly 33.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Synbio Tech's current 14.11% should be judged against Healthcare norms (sector average: 10.58%) and against 1295.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 14.11%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Synbio Tech, and consider following 1295.TWO for alerts when major investors trade the stock.